Welcome to our dedicated page for Sabra Health Care Reit news (Ticker: SBRA), a resource for investors and traders seeking the latest updates and insights on Sabra Health Care Reit stock.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) generates frequent news and disclosures as a self-administered, self-managed real estate investment trust focused on healthcare properties in the United States and Canada. News coverage for SBRA commonly centers on its quarterly financial results, portfolio activity and capital markets actions, all of which provide insight into how the company manages its healthcare real estate platform.
Company press releases often highlight quarterly earnings, including net income, funds from operations (FFO), Adjusted FFO (AFFO) and related non-GAAP measures, along with operating metrics such as EBITDARM coverage for skilled nursing, senior housing and other segments, and same-store Cash NOI trends in its managed senior housing portfolio. These updates give investors and analysts a view into portfolio performance across skilled nursing and transitional care facilities, leased and managed senior housing communities, behavioral health facilities and specialty hospitals and other healthcare properties.
Sabra’s news flow also includes announcements about acquisitions of managed senior housing properties, transitions of senior housing portfolios to new operators, new investment awards and changes in its investment pipeline. Capital structure developments, such as new term loans, redemptions of senior notes, at-the-market equity offering programs and forward sale agreements, are disclosed through press releases and Form 8-K filings and are often discussed in conjunction with earnings.
Other recurring topics in SBRA news include credit rating actions, participation in industry conferences and investor events and senior leadership changes, such as executive appointments and retirements. Together, these updates provide context on Sabra’s strategy, portfolio composition and approach to financing growth. Investors who follow SBRA news can use this page to review earnings releases, transaction announcements, rating updates and corporate communications that shape the company’s healthcare real estate story over time.
Sabra Health Care REIT (SBRA) announced that CEO Rick Matros will present at the WISE Forum on February 28, 2023, in Rancho Santa Fe, California. Other attendees include Chief Investment Officer Talya Nevo-Hacohen and Executive VP of Investments Darrin Smith. The company is also participating in the NIC Spring Conference from March 1-3, 2023, in San Diego, California, with the same executives attending. Additionally, they will take part in Citi's Global Property CEO Conference from March 5-8, 2023, in Hollywood, Florida. Sabra operates as a self-administered and self-managed REIT focused on healthcare real estate across the U.S. and Canada.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has announced gross proceeds of approximately $185 million from disposition activities since September 30, 2022. This includes a significant portfolio of skilled nursing properties sold for over $200,000 per bed, yielding around 7% cash yield for the year ending September 30, 2022. The net proceeds were applied to reduce borrowings under the revolving credit facility. Additionally, 24 properties transitioned from North American to Ensign (Nasdaq: ENSG) and Avamere. CEO Rick Matros highlighted the commitment to capital allocation and balance sheet management amid an uncertain macro environment.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) will release its 2022 fourth quarter earnings on February 21, 2023, after trading closes. A conference call to discuss the results is scheduled for February 22 at 10:00 a.m. Pacific Time, with U.S. participants using the number 888-880-4448. A quarterly cash dividend of $0.30 per share has been declared, payable on February 28, 2023, for shareholders of record by February 13. Visit www.sabrahealth.com for more details.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has announced the tax treatment for its 2022 cash distributions. The total distribution per share is $1.20, which includes $0.87 categorized as ordinary dividends. The dividends consist of $0.22 as non-qualified and $0.08 as qualified dividends. Shareholders need to hold their shares for at least 45 days for dividends to qualify under Section 199A. The company also reported amounts for applicable partnership interests as $0.00. Investors are advised to consult tax advisors regarding the tax implications of these distributions.
Sabra Health Care REIT (NASDAQ: SBRA) will participate in the ASHA’s 2023 Annual Meeting from January 23-25, 2023, at The Westin Kierland in Scottsdale, Arizona. Representing the company will be Talya Nevo-Hacohen, Chief Investment Officer, Darrin Smith, Executive Vice President of Investments, and Eliza Gozar, Senior Vice President of Investments. This event highlights Sabra's commitment to the healthcare real estate sector across the U.S. and Canada.
Sabra Health Care REIT (NASDAQ: SBRA) has amended its credit facility to enhance its debt maturity profile. Key highlights include a $1.0 billion unsecured revolving credit facility maturing in January 2027 with extension options, a $430 million unsecured term loan maturing in January 2028, and a $150 million CAD term loan (~$110 million USD) also maturing in January 2028. The pricing remains consistent with previous terms, linked to adjusted SOFR/CDOR, and an accordion option allows for potential capacity increase to $2.75 billion.
Sabra Health Care REIT (NASDAQ: SBRA) announced its participation in two upcoming virtual conferences. On January 9-10, 2023, Rick Matros (CEO), Michael Costa (CFO), and Talya Nevo-Hacohen (CIO) will represent the company at the Capital One Securities 3rd Annual REIT Conference. Following this, on January 19, 2023, they, along with Darrin Smith (EVP of Investments) and Lukas Hartwich (SVP of Finance), will participate in Stifel's 2023 Seniors Housing and Healthcare Real Estate Conference. These events highlight Sabra's ongoing commitment to the healthcare real estate sector.
Sabra Health Care REIT (SBRA) reported a net loss of $0.22 per diluted share for Q3 2022, with FFO of $0.28 and AFFO of $0.34. Notably, Sabra will transition its 24-property portfolio from North American Health Care to Ensign and Avamere, generating an initial annual rent of $34.5 million. The company is on track to close asset sales generating over $200 million by year-end. As of September 30, 2022, liquidity stood at $887.7 million. A quarterly dividend of $0.30 per share was declared for November 30, 2022.
Sabra Health Care REIT, Inc. (SBRA) announced a transition of its 24-property portfolio from North American Health Care to existing tenants, The Ensign Group (ENSG) and Avamere Family of Companies. After the transition, Ensign will represent about 8% of Sabra's Annualized Cash NOI, adding 20 California properties with an initial rent of $29.4 million, while Avamere adds 4 Washington properties with an initial rent of $5.1 million. This move is expected to enhance rental income stability and improve the portfolio's credit profile, with an estimated revenue of $14.7 million for Q4 2022.
Sabra Health Care REIT (NASDAQ: SBRA) announced its participation in Nareit’s REITworld 2022 Annual Conference from November 15-17, 2022, at the San Francisco Marriott Marquis. Key executives attending include Rick Matros (Chair and CEO), Michael Costa (CFO), Talya Nevo-Hacohen (CIO), and Lukas Hartwich (SVP of Finance). The company, based in Maryland, operates as a self-administered and self-managed REIT, focusing on real estate investments in the healthcare sector across the U.S. and Canada.